Skip to main content


Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study

Fig. 2

Cubic spline regression models of the estimated probability (with 95% confidence interval) of metabolic syndrome according to the adiponectin level. Multiple model adjusted for age, sex, smoking status, body mass index, hemoglobin, serum albumin, uric acid, phosphate, high sensitivity C-reactive protein, urinary albumin-to-creatinine ratio, estimated glomerular filtration rate, coronary artery disease, cerebrovascular disease, angiotensin II receptor blocker, diuretics, statin, ezetimibe, and fibrate

Back to article page